Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia

Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia

Aim. To investigate the effects of simvastatin therapy on antioxidant enzyme activity and the correction of disturbed antioxidant status in patients with coronary heart disease (CHD) – post-infarction cardiosclerosis (PICS) – in combination with dyslipidemia (DLP). Material and methods. The study in...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	N. E. Artamoshina, K. Yu. Bondar, O. L. Belaya, L. M. Bayder, Z. V. Kuropteva
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	«SILICEA-POLIGRAF» LLC 2012-12-01
Schriftenreihe:	Кардиоваскулярная терапия и профилактика
Schlagworte:	simvastatin coronary heart disease antioxidant enzymes ceruloplasmin transferrin
Online Zugang:	https://cardiovascular.elpub.ru/jour/article/view/1955

Ähnliche Einträge

Antioxidant status and lipid peroxidation in stable coronary heart disease patients with dyslipidemia
von: O. L. Belaya, et al.
Veröffentlicht: (2006-10-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
von: F. Yu. Valikulova, et al.
Veröffentlicht: (2014-07-01)

Blood Protein Polymorphism of Small Cattle Bred in Armenia
von: Gayane Marmaryan, et al.
Veröffentlicht: (2023-09-01)

Polymorphism of Blood Serum Protein- Transferrin, Ceruloplasmin, Albumin- in Sheep of Karabakh Breed and the Relationship with the Natural Resistance Towards Epizootic Aphtae
von: Manvel Badalyan, et al.
Veröffentlicht: (2023-09-01)

Clinical effects of statins: focusing on simvastatin
von: D. M. Aronov, et al.
Veröffentlicht: (2009-04-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
von: A. L. Pirogov, et al.
Veröffentlicht: (2007-10-01)

Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment
von: V. Yu. Kopylov
Veröffentlicht: (2020-12-01)

Simvastatin therapy in elderly patients with chronic heart failure: potential cardiodepressive effects
von: A. L. Pirogov, et al.
Veröffentlicht: (2008-10-01)

Serum Level of Ceruloplasmin, Angiotensin-Converting Enzyme and Transferrin as Markers of Severity in SARS-CoV-2 Infection in Patients with Type 2 Diabetes
von: Patricia-Andrada Reștea, et al.
Veröffentlicht: (2023-10-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
von: T. V. Pinchuk, et al.
Veröffentlicht: (2015-09-01)

Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways
von: Lilian Fernandes Silva, et al.
Veröffentlicht: (2022-08-01)

The Suppression of Medulloblastoma Cell Migration Using Clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting
von: Charley Comer, et al.
Veröffentlicht: (2024-03-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
von: T. V. Pinchuk, et al.
Veröffentlicht: (2013-12-01)

In-vitro Examination of The Potential Antibacterial Activity of Simvastatin
von: Hani Almukhtar, et al.
Veröffentlicht: (2020-12-01)

In vitro synergism of simvastatin and fluconazole against Candida species
von: Everardo Albuquerque Menezes, et al.
Veröffentlicht: (2012-08-01)

The effect of Simvastatin in attenuation of Myocardial Ischemia/ Reperfusion injury
von: Najah Raiesh Hadi, et al.
Veröffentlicht: (2013-12-01)

Apoceruloplasmin: Abundance, Detection, Formation, and Metabolism
von: Maria C. Linder
Veröffentlicht: (2021-02-01)

AGED FEATURES OF ANTIOXIDANT PROTECTION UNDER COXIELLOSIS
von: S. F. Karpenko, et al.
Veröffentlicht: (2012-09-01)

Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease
von: Sudip Dhakal, et al.
Veröffentlicht: (2024-06-01)

Effects of simvastatin associated with exercise on the mechanical resistance of muscle and bone in rats
von: Jéssica Suzuki Yamanaka, et al.

Pengaruh Simvastatin Terhadap Kadar Nitric Oxide Makrofag Mencit Balb/C yang Diberi Lipopolisakarida
von: Taufik Eko Nugroho, et al.
Veröffentlicht: (2012-11-01)

Pengaruh Simvastatin Terhadap Kapasitas Fagositosis Makrofag Pada Mencit Balb/C Yang Diberi Lipopolisakharida
von: Sherliyanah Harahap, et al.
Veröffentlicht: (2012-07-01)

THE ANTIOXIDATIVE DEFENCE IN WOMEN WITH EXTERNAL ENDOMETRIOSIS
von: L. V. Adamyan, et al.
Veröffentlicht: (2016-06-01)

Effect of simvastatin on the extraction socket healing in the mandible of prednisolone-treated albino rat
von: Asmaa Fahem, et al.
Veröffentlicht: (2024-03-01)

Pengaruh Simvastatin Terhadap Kadar Proliferasi Limfosit Mencit Balb/C yang Diinduce Sepsis dengan LPS
von: Made Ryan Kharmayani, et al.
Veröffentlicht: (2013-11-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
von: N. B. Amirov, et al.
Veröffentlicht: (1970-01-01)

Simvastatin therapy in climacteric women with atherogenic dyslipoproteinemias
von: N. V. Izmozherova, et al.
Veröffentlicht: (2008-04-01)

STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
von: I. N. Medvedev, et al.
Veröffentlicht: (2013-03-01)

Healing of extraction socket following local application of simvastatin: A split mouth prospective study
von: Aamir Malick Saifi, et al.
Veröffentlicht: (2017-05-01)

PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
von: I. N. Medvedev, et al.
Veröffentlicht: (2010-02-01)

ANTI-TUMOR EFFECTS OF SIMVASTATIN ON UMR-106 OSTEOSARCOMA CELL LINE
von: María Claudia Sandoval-Usme, et al.
Veröffentlicht: (2023-12-01)

Evaluate the efficacy of Simvastatin and Fluvastatin in patients with hypercholesterolemia and their effect on liver functions
von: Hassan A. H. Ali, et al.
Veröffentlicht: (2017-12-01)

Oxidative stress and disruption of the antioxidant defense system as triggers of diseases
von: O. D. Skoryk, et al.
Veröffentlicht: (2023-11-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
von: S. N. Tolpygina, et al.
Veröffentlicht: (2016-01-01)

Antioxidant protection system before and after coronary bypass surgery in coronary heart disease patients with left ventricular dysfunction
von: L. A. Bokeriya, et al.
Veröffentlicht: (2004-12-01)

COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN
von: E. I. Tarlovskaya, et al.
Veröffentlicht: (2016-01-01)

Study of some Antioxidants in plasma of patients with bladder cancer
von: Israa G. Zainal, et al.
Veröffentlicht: (2009-03-01)

Simvastatin in primary and secondary prevention of cerebrovascular insufficiency
von: E. A. Melnik, et al.
Veröffentlicht: (2007-12-01)

Can Simvastatin Reduce the Need for Immunomodulatory Drugs to Treat Uveitis?
von: Ahmed Al-Janabi, PhD, FRCOphth, et al.
Veröffentlicht: (2023-12-01)

Lipid peroxidation, antioxidant protection, and rheology disturbances in coronary heart disease pathogenesis
von: A. N. Zakirova, et al.
Veröffentlicht: (2006-04-01)